Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Pharmaceuticals & Biotech
Create a narrative
Alvotech Community
NasdaqGM:ALVO Community
1
Narratives
written by author
0
Comments
on narratives written by author
16
Fair Values set
on narratives written by author
Create a narrative
Alvotech
Popular
Undervalued
Overvalued
Community Investing Ideas
Alvotech
AN
AnalystConsensusTarget
Consensus Narrative from 5 Analysts
Aging Populations And New Biosimilars Will Transform Global Markets
Key Takeaways Rising global demand for biologic therapies and biosimilar adoption are driving market expansion and positioning Alvotech for sustained growth. Diversified pipeline and international partnerships enhance revenue stability, reduce single-product risk, and improve overall financial flexibility and margins.
View narrative
US$17.50
FV
47.7% undervalued
intrinsic discount
32.65%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
6
users have followed this narrative
1 day ago
author updated this narrative
Your Valuation for
ALVO
ALVO
Alvotech
Your Fair Value
US$
Current Price
US$9.16
50.4% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-713m
2b
2015
2018
2021
2024
2025
2027
2030
Revenue US$1.7b
Earnings US$280.5m
Advanced
Set Fair Value